Iovance Biotherapeutics Inc. sell StockNews.com
Start price
01.07.23
/
50%
€6.50
Target price
01.07.24
-
Performance (%)
16.15%
End price
02.07.24
€7.55
Summary
This prediction ended on 02.07.24 with a price of €7.55. The prediction closed with a disappointing performance of 16.15%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Iovance Biotherapeutics Inc. | 10.609% | 10.609% | -71.249% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by StockNews_com for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for IOVA provided by MarketBeat
In the thread Trading Iovance Biotherapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.52
09.09.23
09.09.23
-
09.09.24
09.09.24
47.24%
10.09.24
10.09.24
